Roundup Litigation

Since 2015, the World Health Organization (WHO) has considered glyphosate, the main ingredient in Monsanto’s Roundup®, to be “probably carcinogenic.” Since then, there have been over 100,000 lawsuits alleging the product’s connection with the development of Non-Hodgkin’s Lymphoma, Large Diffuse B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, and Cutaneous T-Cell Lymphoma.

If you have worked with Roundup® and have been diagnosed with one of these conditions, you may be entitled to financial compensation for your injuries. An injured plaintiff may seek damages against Monsanto for:

  • Past and future medical expenses to treat your cancer
  • Past and future pain and suffering that results from your injuries
  • Wage loss
  • Punitive damages (in some cases)

In 2018, German pharmaceutical giant Bayer purchased Monsanto and inherited all of the company’s legal problems. In addition to a multitude of awards paid out in previous cases, in May 2022, Bayer/Monsanto agreed to pay approximately $11 billion to settle nearly 100,000 roundup lawsuits. Although this resolved about 80% of all pending Roundup® claims, there are still an estimated 26,000 to 30,000 active lawsuit trials. In addition, more lawsuits have continued flowing in. 

While most of the current lawsuits have been filed in state court, there are also over 4,000 claims in a federal “multidistrict litigation” (MDL) Roundup® class action lawsuit pending in California.

Bayer Settlements for Roundup®

Shortly after Bayer bought Monsanto in 2018, the company was hit with thousands of lawsuits linking Roundup® to the development of non-Hodgkin's lymphoma. Some resulted in huge settlements for the plaintiffs. This includes:

  • Johnson v Monsanto (August 2018) - $289.2 million
  • Hardeman v Monsanto (February 2019) - $80.2 million
  • Pilliod v Monsanto (May 2019)- $2.055 billion

Bayer's settlement agreement includes no admission of wrongdoing, and as of now, they continue to sell the product without any warning labels. However, in July of 2021, the company announced that it will stop selling glyphosate-based Roundup® to the public in 2023. While they still are not admitting there is anything wrong with the product, Bayer hopes that this move will help minimize future lawsuits. The new formulation of Roundup® will use “alternative active ingredients,” subject to review and approval from state safety agencies and the U.S. Environmental Protection Agency.

Read moreBayer to Pull Roundup from Store Shelves to Avoid More Lawsuits

Recent Roundup® Updates

Much has happened since 2020 when Bayer originally proposed a $10 billion global settlement to resolve existing claims. In addition to the settlement, this proposal also included the creation of a controversial scientific panel that would decide the fate of all future claims. After the final approval of the proposal was delayed for many months, in May 2021 a judge rejected it. In August 2021, Bayer put aside $4.5 billion to pay future claims.

The company achieved four victories in a row when it won cases in October and December of 2021 and again in January and June of 2022. While this could potentially be bad news for plaintiffs, it's important to note that Bayer has been settling cases it does not want to go to trial and trying cases it thinks it can win. 

On June 21st, 2022, the U.S. Supreme Court formally declined to hear an appeal from Bayer that could have reversed the current course for Roundup® litigation and ended any future litigation. The remaining trials are still ongoing.

Some of the plaintiffs involved in the recent Roundup® lawsuits received their settlements checks in 2021 and 2022. Many others will receive their Roundup® settlement money in the near future, as the rest of the settlements are processed. 

Chronic Lymphocytic Leukemia and Roundup® Lawsuits

Chronic Lymphocytic Leukemia (CLL) is the most common type of leukemia or cancer of the blood. It can take a few years for symptoms to develop after developing in bone marrow and moving into the blood. In 2015, the International Agency for Research on Cancer classified glyphosate as a “probable human carcinogen” based on studies linking it to blood cancers, including CLL. That same year, a woman who had been diagnosed with CLL and had been exposed to Roundup® filed suit against the company. Others have followed in the years since.

Read more7 Key Factors that Can Affect Your Roundup Claim

Lymphoma and Roundup® Lawsuits

Glyphosate has also been linked to cases of non-Hodgkin's lymphoma and b-cell lymphoma, and many of the cases against Roundup are by plaintiffs who have lymphoma. Bayer’s $11 billion 2022 agreement includes settlements designated for potential future claims from Roundup users who may develop non-Hodgkin’s lymphoma.

Study Linking Roundup® to Parkinson’s Disease

Not only has glyphosate been linked to the development of non-Hodgkin’s lymphoma and other forms of cancer, but a new study, published in the Journal of Neuroinflammation on July 28, 2022, found that the chemical may also increase the risk of developing Parkinson’s disease and other neurologic disorders.

There have long been patients with Parkinson’s disease who claimed that exposure to Roundup® caused their condition, but they have not been included in any of the class action suits. However, the release of this study may open up the door for another wave of Roundup® lawsuits coming from Parkinson's patients.

Chicago Roundup® Lawsuit Attorneys

If you or a loved one has used Monsanto’s Roundup® and developed cancer, you may be entitled to financial compensation. Despite the current settlement agreement, it's not too late to file your own Roundup® lawsuit. Class action lawsuits continue to be filed and the third wave of suits is currently being prepared for trial. 

However, it’s important to note that each state is governed by a specific statute of limitations that gives potential plaintiffs a deadline to file. Therefore, individuals who wish to file a Roundup® lawsuit are urged to contact an attorney as soon as possible.

The experts at Cooney & Conway are here to protect your legal rights. To learn more about whether you may be eligible to file a Roundup® lawsuit, please call us toll-free at 800-322-5573 or fill out the form below and our team will be in touch with you shortly.

Submit a Free Case Evaluation to a Cooney & Conway Attorney